Kraig Biocraft Laboratories Secures Four Registered Trademarks for SpydaSilk® Brand, to Advance Commercialization Strategy for Recombinant Spider Silk
Kraig Biocraft Laboratories (OTCQB: KBLB) has secured four registered trademarks for its SpydaSilk® brand, marking a significant milestone in its commercialization strategy for recombinant spider silk technology. SpydaSilk®, a Singapore-based joint venture founded in 2021, serves as a direct-to-consumer marketing channel for the company's spider silk materials.
The company is pursuing a dual-track approach by developing SpydaSilk® as a standalone brand while seeking collaborations with industry leaders in luxury fashion and high-performance apparel. Kraig Labs' proprietary recombinant spider silk fibers combine strength, elasticity, and softness, targeting high-value applications.
With recent production expansion, the company focuses on optimizing spider silk output and finalizing product designs for commercialization, aiming to accelerate technology adoption and drive revenue growth through this blended strategy.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha ottenuto quattro marchi registrati per il suo marchio SpydaSilk®, segnando un traguardo significativo nella sua strategia di commercializzazione per la tecnologia della seta di ragno ricombinante. SpydaSilk®, una joint venture con sede a Singapore fondata nel 2021, funge da canale di marketing diretto al consumatore per i materiali in seta di ragno dell'azienda.
L'azienda sta perseguendo un approccio a doppio binario sviluppando SpydaSilk® come marchio autonomo mentre cerca collaborazioni con leader del settore nella moda di lusso e nell'abbigliamento ad alte prestazioni. Le fibre di seta di ragno ricombinante proprietarie di Kraig Labs combinano resistenza, elasticità e morbidezza, mirate a applicazioni di alto valore.
Con l'espansione recente della produzione, l'azienda si concentra sull'ottimizzazione della produzione di seta di ragno e sulla finalizzazione dei design dei prodotti per la commercializzazione, puntando ad accelerare l'adozione della tecnologia e a guidare la crescita dei ricavi attraverso questa strategia mista.
Kraig Biocraft Laboratories (OTCQB: KBLB) ha asegurado cuatro marcas registradas para su marca SpydaSilk®, marcando un hito significativo en su estrategia de comercialización para la tecnología de seda de araña recombinante. SpydaSilk®, una empresa conjunta con sede en Singapur fundada en 2021, actúa como un canal de marketing directo al consumidor para los materiales de seda de araña de la compañía.
La empresa está siguiendo un enfoque de doble vía desarrollando SpydaSilk® como una marca independiente mientras busca colaboraciones con líderes de la industria en moda de lujo y ropa de alto rendimiento. Las fibras de seda de araña recombinante propietarias de Kraig Labs combinan resistencia, elasticidad y suavidad, enfocándose en aplicaciones de alto valor.
Con la reciente expansión de la producción, la empresa se centra en optimizar la producción de seda de araña y en finalizar los diseños de productos para la comercialización, con el objetivo de acelerar la adopción de la tecnología y impulsar el crecimiento de ingresos a través de esta estrategia combinada.
Kraig Biocraft Laboratories (OTCQB: KBLB)는 SpydaSilk® 브랜드에 대해 네 개의 등록 상표를 확보하여 재조합 거미 실크 기술 상용화 전략에서 중요한 이정표를 세웠습니다. SpydaSilk®은 2021년에 설립된 싱가포르 기반의 합작 투자로, 회사의 거미 실크 소재를 위한 직접 소비자 마케팅 채널 역할을 합니다.
회사는 SpydaSilk®을 독립 브랜드로 개발하는 동시에 고급 패션 및 고성능 의류 분야의 산업 리더들과의 협업을 추구하는 이중 경로 접근 방식을 취하고 있습니다. Kraig Labs의 독점 재조합 거미 실크 섬유는 강도, 탄력성 및 부드러움을 결합하여 고부가가치 응용 프로그램을 목표로 합니다.
최근 생산 확장과 함께, 회사는 거미 실크 생산 최적화와 상용화를 위한 제품 디자인 최종화에 집중하고 있으며, 이 혼합 전략을 통해 기술 채택을 가속화하고 수익 성장을 추진하는 것을 목표로 하고 있습니다.
Kraig Biocraft Laboratories (OTCQB: KBLB) a obtenu quatre marques déposées pour sa marque SpydaSilk®, marquant une étape importante dans sa stratégie de commercialisation pour la technologie de soie d'araignée recombinante. SpydaSilk®, une coentreprise basée à Singapour fondée en 2021, sert de canal de marketing direct au consommateur pour les matériaux en soie d'araignée de l'entreprise.
L'entreprise adopte une approche à double voie en développant SpydaSilk® en tant que marque autonome tout en recherchant des collaborations avec des leaders de l'industrie dans la mode de luxe et les vêtements haute performance. Les fibres de soie d'araignée recombinantes propriétaires de Kraig Labs combinent résistance, élasticité et douceur, visant des applications de grande valeur.
Avec l'expansion récente de la production, l'entreprise se concentre sur l'optimisation de la production de soie d'araignée et la finalisation des designs de produits pour la commercialisation, visant à accélérer l'adoption de la technologie et à stimuler la croissance des revenus grâce à cette stratégie mixte.
Kraig Biocraft Laboratories (OTCQB: KBLB) hat vier eingetragene Marken für seine Marke SpydaSilk® gesichert, was einen bedeutenden Meilenstein in seiner Kommerzialisierungsstrategie für rekombinante Spinnenseide-Technologie darstellt. SpydaSilk®, ein 2021 gegründetes Joint Venture mit Sitz in Singapur, dient als Direktvertriebskanal für die Spinnenseidenmaterialien des Unternehmens.
Das Unternehmen verfolgt einen dualen Ansatz, indem es SpydaSilk® als eigenständige Marke entwickelt und gleichzeitig Kooperationen mit Branchenführern in der Luxusmode und im Hochleistungsbekleidungssektor anstrebt. Die proprietären rekombinanten Spinnenseidefasern von Kraig Labs kombinieren Stärke, Elastizität und Weichheit und zielen auf hochpreisige Anwendungen ab.
Mit der kürzlichen Produktionsausweitung konzentriert sich das Unternehmen darauf, die Spinnenseideproduktion zu optimieren und die Produktdesigns für die Kommerzialisierung abzuschließen, mit dem Ziel, die Technologieadoption zu beschleunigen und das Umsatzwachstum durch diese gemischte Strategie voranzutreiben.
- Secured legal protection for SpydaSilk® brand through four trademark registrations
- Recent expansion of production operations
- Dual revenue strategy through direct brand development and industry partnerships
- None.
ANN ARBOR, Mich., April 01, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or the "Company"), a world leader in recombinant spider silk technology, today announced that it has secured four registered trademarks for its SpydaSilk® brand. These trademarks represent a key milestone in the Company's strategy to commercialize its revolutionary spider silk technology and position SpydaSilk® as a premium apparel brand.
The newly secured trademarks provide legal protection for the SpydaSilk® brand as Kraig Labs continues to expand its production capabilities and moves toward commercialization. SpydaSilk® is a Singapore based joint venture company that Kraig Labs co-founded in 2021 to create a direct-to-consumer marketing channel for its spider silk materials. The Company is leveraging a blended strategy that includes both the independent development of the SpydaSilk® brand and outreach to leading companies in key target markets, such as luxury fashion and high-performance apparel.
"The registration of these trademarks reinforces our commitment to building SpydaSilk® into a globally recognized brand focused on quality and exceptional material performance," said Kim Thompson, CEO and Founder of Kraig Labs. "With our spider silk production scaling up, we are positioning ourselves to introduce breakthrough products that merge sustainability with performance. We are actively engaging with industry leaders to explore collaborative opportunities that will bring our innovative materials to market."
The Company’s proprietary recombinant spider silk fibers offer a combination of strength, elasticity, and softness, making them ideal for a range of high-value applications. Kraig Labs is engaging opportunities in luxury fashion and technical textiles to integrate its materials into next-generation products that redefine performance and sustainability standards.
With the recent expansion of its production operations, Kraig Labs remains focused on optimizing its recombinant spider silk output and finalizing product designs for commercialization. The Company anticipates that its dual-track approach—developing SpydaSilk® as a standalone brand while also collaborating with industry leaders—will accelerate the adoption of its technology and drive revenue growth.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC
(720) 288-8495
ir@KraigLabs.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5cccbae8-abda-486a-8a50-af809a8e1059
FAQ
What is the significance of KBLB's four new trademark registrations for SpydaSilk®?
How is KBLB planning to commercialize its spider silk technology?
When was the SpydaSilk® joint venture established and what is its purpose?
What are the key properties of KBLB's recombinant spider silk fibers?
